ELIZABETH BENFIELD: Open Payments
NPI 1700972890 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,117 in 58 payments from 13 companies in 2025. Trend: 2023 $2,677 · 2024 $2,444 · 2025 $1,117
Food & beverage: $1,117
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $214 |
| PFIZER INC. | 23 | $202 |
| Janssen Biotech, Inc. | 2 | $147 |
| UCB, Inc. | 6 | $144 |
| AstraZeneca Pharmaceuticals LP | 1 | $132 |
| ABBVIE INC. | 3 | $72 |
| GENZYME CORPORATION | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| Organon LLC | 1 | $26 |
| Fresenius Kabi USA, LLC | 1 | $26 |
Products named: XELJANZ, TREMFYA, Bimzelx, SAPHNELO, OTEZLA, TAVNEOS, KRYSTEXXA, SKYRIZI.
Industry payments across NC — which companies pay providers there.
